Montclair, NJ, United States of America

Vivian R Albert

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Vivian R. Albert

Introduction

Vivian R. Albert, based in Montclair, NJ, is a notable inventor recognized for his contributions to the field of neuroscience. With a total of five patents under his name, Albert's work primarily focuses on the development of innovative solutions for glycine transporters, which are crucial in the functioning of the nervous system.

Latest Patents

Among his latest innovations, Albert has developed a patent concerning the Glycine transporter. This invention provides nucleic acid sequences that encode the GlyT1d form of the glycine transporter. It also includes vectors and methods for producing the transporter, alongside methods for identifying bioactive agents. These advancements have the potential to significantly impact therapeutic approaches in neurology.

Career Highlights

Vivian R. Albert has made substantial contributions during his tenure at Allelix Neuroscience Inc. His unique approach to research and development has led to impactful discoveries in understanding glycine transport mechanisms, which are paramount in various neurological disorders.

Collaborations

Throughout his career, Albert has collaborated with esteemed colleagues, including Laurence A. Borden and Leslie R. Kowalski, who bring diverse expertise to their joint research efforts. These collaborations are instrumental in advancing their shared vision of improving neurological health through innovative therapies.

Conclusion

In summary, Vivian R. Albert's contributions as an inventor at Allelix Neuroscience Inc. have established him as a pivotal figure in the advancement of science related to glycine transporters. His ongoing innovations continue to inspire future research and have the potential to transform therapeutic strategies in treating neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…